eMedicine Specialties > Pediatrics: General Medicine > Endocrinology
Growth Failure: Follow-up
Updated: Sep 15, 2009
Follow-up
Further Outpatient Care
- While the cause of growth failure is being investigated, most practitioners prefer to reevaluate patients at intervals of 3 months. This amount of time also permits repeated growth measurements, which then allows an estimation of growth velocity.
Prognosis
- Prognosis for adult stature depends on the cause of the growth failure. Initiating therapeutic intervention is important before the patient has closure of the epiphyses with the concomitant finishing of the growth process. If a diagnosis of hypothyroidism or growth hormone (GH) deficiency is made, replacement of the deficient hormone usually results in a period of rapid catch-up growth, with subsequent normal growth until epiphyseal fusion.
Patient Education
- For excellent patient education resources, visit eMedicine's Growth Hormone Deficiency Center. Also, see eMedicine's patient education articles Growth Failure in Children, Growth Hormone Deficiency, Understanding Growth Hormone Deficiency Medications, and Growth Hormone Deficiency FAQs.
Miscellaneous
Medicolegal Pitfalls
- The most significant medicolegal pitfall is overlooking a CNS tumor with growth failure as its manifestation. Although CNS tumors also often produce neurological symptoms, such as headache with nausea and vomiting or visual changes, 10% of children diagnosed with craniopharyngioma present with growth failure as the only symptom. Importantly, these children are presenting with growth failure (a slow growth velocity) and not just short stature.
- Delayed diagnosis of a treatable cause of growth failure is another pitfall. Once the epiphyses are fused, correction of the cause of the growth failure does not result in further growth.
Special Concerns
- Children with short stature are frequently teased. Western culture is more accepting of short stature in girls than in boys, a concept that is imbedded in the language. Short girls are often described as petite or cute, whereas terms used to describe short boys are more often pejorative. Studies of children with growth hormone deficiency have shown that these children tend to have normal intelligence but demonstrate poor school performance. They also tend to have more abnormalities on the child behavior checklist. Growth hormone therapy results in improvement.
More on Growth Failure |
| Overview: Growth Failure |
| Differential Diagnoses & Workup: Growth Failure |
| Treatment & Medication: Growth Failure |
Follow-up: Growth Failure |
| Multimedia: Growth Failure |
| References |
| « Previous Page | Next Page » |
References
[Guideline] New York State Department of Health. Growth, body composition, and metabolism. New York (NY): New York State Department of Health; 2007 Nov. [Full Text].
Lindsay R, Feldkamp M, Harris D. Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr. Jul 1994;125(1):29-35. [Medline].
Lacey KA, Parkin JM. Causes of short stature. A community study of children in Newcastle upon Tyne. Lancet. Jan 12 1974;1(7846):42-5. [Medline].
Carrel AL, Allen DB. Effects of growth hormone on body composition and bone metabolism. Endocrine. Apr 2000;12(2):163-72. [Medline].
Grimberg A, Kutikov JK, Cucchiara AJ. Sex differences in patients referred for evaluation of poor growth. J Pediatr. Feb 2005;146(2):212-6. [Medline].
Hindmarsh PC, Brook CG. Short stature and growth hormone deficiency. Clin Endocrinol (Oxf). Aug 1995;43(2):133-42. [Medline].
Hintz RL. Growth hormone treatment of idiopathic short stature. Horm Res. 1996;46(4-5):208-14. [Medline].
Hintz RL. Disorders of growth. In: Brunwald E, Fauci AS, Isselbacher KJ, et al, eds. Harrison's Principles of Internal Medicine. 13th ed. New York, NY: McGraw-Hill Medical Publishing Division; 1994.
Horner JM, Thorsson AV, Hintz RL. Growth deceleration patterns in children with constitutional short stature: an aid to diagnosis. Pediatrics. Oct 1978;62(4):529-34. [Medline].
Kojima M, Hosoda H, Date Y. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. Dec 9 1999;402(6762):656-60. [Medline].
Kojima M, Hosoda H, Matsuo H. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab. Apr 2001;12(3):118-22. [Medline].
Stabler B, Clopper RR, Siegel PT, et al. Academic achievement and psychological adjustment in short children. The National Cooperative Growth Study. J Dev Behav Pediatr. Feb 1994;15(1):1-6. [Medline].
Stabler B, Siegel PT, Clopper RR, et al. Behavior change after growth hormone treatment of children with short stature. J Pediatr. Sep 1998;133(3):366-73. [Medline].
Tanner JM. Fetus into Man: Physical Growth from Conception to Maturity. Cambridge, Mass: Harvard University Press; 1990.
Tanner JM. Normal growth and techniques of growth assessment. Clin Endocrinol Metab. Aug 1986;15(3):411-51. [Medline].
Zemel B. The recognition and treatment of growth disorders - a 50-year retrospective. Ann Hum Biol. Sep-Oct 2009;36(5):496-510. [Medline].
Further Reading
Keywords
slow growth velocity, short stature, growth hormone, GH, GH secretion, growth hormone–releasing hormone, GHRH, growth hormone–releasing peptide, GHRP, ghrelin, growth deficiency, GH deficiency, delayed puberty, slow growth velocity, idiopathic short stature, ISS, growth failure, familial short stature, constitutional delay, Gh deficiency, Turner syndrome, hypothyroidism, Down syndrome, cystic fibrosis, chronic renal insufficiency, juvenile rheumatoid arthritis, Hurler syndrome, intrauterine growth retardation, Noonan syndrome, Russell-Silver syndrome, skeletal dysplasia, microcephaly, cyanotic heart disease, gluten enteropathy, ulcerative colitis, Crohn disease, inflammatory bowel disease, renal tubular acidosis, dermatomyositis, psychosocial dwarfism, Prader-Willi syndrome, fetal alcohol syndrome, placental insufficiency syndrome, achondroplasia, hypochondroplasia, thyroid hormone deficiency, Laron dwarfism, Cushing syndrome, Cushing disease, androgen excess, treatment, diagnosis
Follow-up: Growth Failure